407 related articles for article (PubMed ID: 23786593)
1. Mean platelet volume is decreased during an acute exacerbation of chronic obstructive pulmonary disease.
Wang RT; Li JY; Cao ZG; Li Y
Respirology; 2013 Nov; 18(8):1244-8. PubMed ID: 23786593
[TBL] [Abstract][Full Text] [Related]
2. A decreased mean platelet volume is associated with stable and exacerbated asthma.
Sun WX; Zhang JR; Cao ZG; Li Y; Wang RT
Respiration; 2014; 88(1):31-7. PubMed ID: 24854778
[TBL] [Abstract][Full Text] [Related]
3. Mean platelet volume is elevated in exacerbated and convalescent COPD patients.
Zhang M; Li Y; Zhang J; Zhang Q; Yang X; Shan H; Xie Y; Jin Q; Feng X
Clin Chim Acta; 2015 Dec; 451(Pt B):227-31. PubMed ID: 26436484
[TBL] [Abstract][Full Text] [Related]
4. Circulating vascular endothelial growth factor and systemic inflammatory markers in patients with stable and exacerbated chronic obstructive pulmonary disease.
Valipour A; Schreder M; Wolzt M; Saliba S; Kapiotis S; Eickhoff P; Burghuber OC
Clin Sci (Lond); 2008 Oct; 115(7):225-32. PubMed ID: 18307413
[TBL] [Abstract][Full Text] [Related]
5. Platelet activation and cardiovascular comorbidities in patients with chronic obstructive pulmonary disease.
Malerba M; Olivini A; Radaeli A; Ricciardolo FL; Clini E
Curr Med Res Opin; 2016 May; 32(5):885-91. PubMed ID: 26824631
[TBL] [Abstract][Full Text] [Related]
6. The Role of Mean Platelet Volume in Chronic Obstructive Pulmonary Disease Exacerbation.
Agapakis DI; Massa EV; Hantzis I; Maraslis S; Alexiou E; Imprialos KP; Damianidou M; Satsoglou E
Respir Care; 2016 Jan; 61(1):44-9. PubMed ID: 26604328
[TBL] [Abstract][Full Text] [Related]
7. Platelet count, mean platelet volume and smoking status in stable chronic obstructive pulmonary disease.
Biljak VR; Pancirov D; Cepelak I; Popović-Grle S; Stjepanović G; Grubišić TŽ
Platelets; 2011; 22(6):466-70. PubMed ID: 21506665
[TBL] [Abstract][Full Text] [Related]
8. Mean platelet volume as an inflammatory marker in acute exacerbation of chronic obstructive pulmonary disease.
Ulasli SS; Ozyurek BA; Yilmaz EB; Ulubay G
Pol Arch Med Wewn; 2012; 122(6):284-90. PubMed ID: 22576316
[TBL] [Abstract][Full Text] [Related]
9. The neutrophil/lymphocyte ratio is a better addition to C-reactive protein than CD64 index as a marker for infection in COPD.
Farah R; Ibrahim R; Nassar M; Najib D; Zivony Y; Eshel E
Panminerva Med; 2017 Sep; 59(3):203-209. PubMed ID: 28185443
[TBL] [Abstract][Full Text] [Related]
10. Alterations of the neutrophil-lymphocyte ratio during the period of stable and acute exacerbation of chronic obstructive pulmonary disease patients.
Taylan M; Demir M; Kaya H; Selimoglu Sen H; Abakay O; Carkanat Aİ; Abakay A; Tanrikulu AC; Sezgi C
Clin Respir J; 2017 May; 11(3):311-317. PubMed ID: 26096858
[TBL] [Abstract][Full Text] [Related]
11. Mean platelet volume and platelet distribution width in patients with chronic obstructive pulmonary disease: the role of comorbidities.
Steiropoulos P; Papanas N; Nena E; Xanthoudaki M; Goula T; Froudarakis M; Pita E; Maltezos E; Bouros D
Angiology; 2013 Oct; 64(7):535-9. PubMed ID: 23052724
[TBL] [Abstract][Full Text] [Related]
12. [Etiology and biomarkers of systemic inflammation in mild to moderate COPD exacerbations].
Saldías PF; Díaz PO; Dreyse DJ; Gaggero BA; Sandoval AC; Lisboa BC
Rev Med Chil; 2012 Jan; 140(1):10-8. PubMed ID: 22552550
[TBL] [Abstract][Full Text] [Related]
13. Platelet function in diabetic and nondiabetic patients with chronic obstructive pulmonary disease: a case control study.
Makhlouf HA; Sadek SH; Nafady AAH
Clin Respir J; 2018 Jan; 12(1):48-56. PubMed ID: 27003100
[TBL] [Abstract][Full Text] [Related]
14. Gamma-glutamyltransferase and C-reactive protein in stable chronic obstructive pulmonary disease.
Biljak VR; Rumora L; Cepelak I; Pancirov D; Popović-Grle S; Sorić J; Stjepanović G; Grubisić TZ
Coll Antropol; 2013 Mar; 37(1):221-7. PubMed ID: 23697277
[TBL] [Abstract][Full Text] [Related]
15. [Is microembolism present and is it important element of COPD exacerbation?].
Karwat K; Kościuch J; Chazan R
Pol Merkur Lekarski; 2005 Apr; 18(106):385-8. PubMed ID: 16161916
[TBL] [Abstract][Full Text] [Related]
16. Dysregulated adipokine metabolism in chronic obstructive pulmonary disease.
Breyer MK; Rutten EP; Locantore NW; Watkins ML; Miller BE; Wouters EF;
Eur J Clin Invest; 2012 Sep; 42(9):983-91. PubMed ID: 22703238
[TBL] [Abstract][Full Text] [Related]
17. Growth Differentiation Factor-15 Is a Novel Biomarker Predicting Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
Mutlu LC; Altintas N; Aydin M; Tulubas F; Oran M; Kucukyalin V; Kaplan G; Gurel A
Inflammation; 2015 Oct; 38(5):1805-13. PubMed ID: 25820390
[TBL] [Abstract][Full Text] [Related]
18. Evaluating the clinical role of fibrinogen, D-dimer, mean platelet volume in patients with acute exacerbation of COPD.
Chen L; Xu W; Chen J; Zhang H; Huang X; Ma L; Yu G; Zhou Y; Ma B; Chen C; Liu Y; Ma X
Heart Lung; 2023; 57():54-58. PubMed ID: 36057186
[TBL] [Abstract][Full Text] [Related]
19. Leptin and TNF-alpha levels in patients with chronic obstructive pulmonary disease and their relationship to nutritional parameters.
Calikoglu M; Sahin G; Unlu A; Ozturk C; Tamer L; Ercan B; Kanik A; Atik U
Respiration; 2004; 71(1):45-50. PubMed ID: 14872110
[TBL] [Abstract][Full Text] [Related]
20. Dynamic pulmonary hyperinflation and low grade systemic inflammation in stable COPD patients.
Gatta D; Aliprandi G; Pini L; Zanardini A; Fredi M; Tantucci C
Eur Rev Med Pharmacol Sci; 2011 Sep; 15(9):1068-73. PubMed ID: 22013730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
